TAK-937

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C27H37NO3
Molecular Weight	423.5876
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC(C)C1=CC=C(C=C1)[C@H]2COC3=C([C@@H](C)O)C(C)=C(NC(=O)CC(C)(C)C)C(C)=C23

InChI

InChIKey=BYDCZCJSMIDWLD-WIYYLYMNSA-N

InChI=1S/C27H37NO3/c1-15(2)19-9-11-20(12-10-19)21-14-31-26-23(18(5)29)16(3)25(17(4)24(21)26)28-22(30)13-27(6,7)8/h9-12,15,18,21,29H,13-14H2,1-8H3,(H,28,30)/t18-,21-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C27H37NO3
Molecular Weight	423.5876
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Wed Apr 02 19:52:45 GMT 2025` Edited by `admin` on `Wed Apr 02 19:52:45 GMT 2025`
Record UNII	22U7BFN52P
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Butanamide, N-[(3R)-2,3-dihydro-7-[(1R)-1-hydroxyethyl]-4,6-dimethyl-3-[4-(1-methylethyl)phenyl]-5-benzofuranyl]-3,3-dimethyl-

Preferred Name

English

TAK-937

Common Name

English

N-[(3R)-2,3-Dihydro-7-[(1R)-1-hydroxyethyl]-4,6-dimethyl-3-[4-(1-methylethyl)phenyl]-5-benzofuranyl]-3,3-dimethylbutanamide

Systematic Name

English

Code System Code Type Description

FDA UNII

22U7BFN52P

Created by admin on Wed Apr 02 19:52:45 GMT 2025 , Edited by admin on Wed Apr 02 19:52:45 GMT 2025

PRIMARY

CAS

1306764-05-5

Created by admin on Wed Apr 02 19:52:45 GMT 2025 , Edited by admin on Wed Apr 02 19:52:45 GMT 2025

PRIMARY

PUBCHEM

49869061

Created by admin on Wed Apr 02 19:52:45 GMT 2025 , Edited by admin on Wed Apr 02 19:52:45 GMT 2025

PRIMARY

Related Record Type Details


					NJ1Q2Q7LO5

CANNABINOID RECEPTOR 1

TARGET -> AGONIST

Qualification:

IC50

Amount:


					SKEU5X23RI

CANNABINOID RECEPTOR 2

TARGET -> AGONIST

Qualification:

IC50

Amount:

Related Record Type Details


					22U7BFN52P

TAK-937

ACTIVE MOIETY

Comments:

Has cerebroprotective effects. Could be a novel therapeutic agent for acute ischemic stroke.

Amount: